"Super p53" mice display retinal astroglial changes

Juan J Salazar1, Roberto Gallego-Pinazo, Rosa de Hoz

  • 1Instituto de Investigaciones Oftalmológicas "Ramón Castroviejo", Universidad Complutense de Madrid, Madrid, Spain.

Plos One
|June 14, 2013
PubMed

Insights

Increased p53 gene copies in mice enhanced astrocyte size and density in the retina. This suggests a potential protective role for p53 against retinal oxidative stress.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Genetics

Background:

  • Tumor suppressor p53 protein regulates cell division in response to DNA damage, hypoxia, and oxidative stress (OS).
  • Astrocytic p53 plays a role in neurodegenerative diseases and retinal responses to OS and hypoxia.
  • The influence of p53 on retinal astrocyte structure and quantity requires further investigation.

Purpose of the Study:

  • To investigate the impact of increased p53 gene copies on the structural and quantitative characteristics of retinal astrocytes.
  • To assess potential alterations in astrocyte morphology and density in response to varying p53 levels.

Main Methods:

  • Adult C57BL/6 mice were divided into two groups: "super p53" (two extra p53 copies) and wild-type (WT) controls.
  • Retinal immunohistochemistry was performed to detect glial fibrillary acidic protein (GFAP)-expressing astrocytes.
  • Manual counting and area quantification of GFAP+ astrocytes were conducted to assess density and size.

Main Results:

  • Mice with "super p53" exhibited significantly larger mean GFAP+ astrocyte areas compared to WT controls (p<0.05).
  • Astroglial density was significantly higher in "super p53" retinas than in WT retinas across the whole retina (p<0.01) and specific regions (p<0.05).

Conclusions:

  • Elevated p53 levels alter retinal astrocyte morphology, increasing individual cell size and overall astroglial density.
  • These structural changes in astrocytes may enhance retinal cell resistance to oxidative stress and its signaling pathways.
  • Further research is warranted to elucidate the therapeutic potential of modulating p53 in ocular diseases.

Related Concept Videos